Crossref
Retraction Note: Telomerase gene therapy: a remission toward cancer
Medical Oncology · 26.06.2026 · 43 (8)
DOI: 10.1007/s12032-026-03327-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, online erschienen am 26.06.2026. Verfasst von Sameer Quazi. Beteiligte Einrichtung: GenLab Biosolutions Private Limited, Bangalore, 560043, Karnataka, India. Colonel.quazi@gmail.com.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- GenLab Biosolutions Private Limited, Bangalore, 560043, Karnataka, India. Colonel.quazi@gmail.com.
- Department of Biomedical Sciences, School of Life Science, Anglia Ruskin University, Cambridge, UK. Colonel.quazi@gmail.com.
Zitieren
APA
Quazi, S. (2026). Retraction Note: Telomerase gene therapy: a remission toward cancer. Medical Oncology, 43(8). https://doi.org/10.1007/s12032-026-03327-1
Vancouver
Quazi S. Retraction Note: Telomerase gene therapy: a remission toward cancer. Medical Oncology. 2026;43(8). doi:10.1007/s12032-026-03327-1
BibTeX
@article{Quazi2026,
author = {Quazi, Sameer},
title = {Retraction Note: Telomerase gene therapy: a remission toward cancer},
journal = {Medical Oncology},
year = {2026},
volume = {43},
number = {8},
doi = {10.1007/s12032-026-03327-1}
}
EUVIMED